L

LGC Group

Sells oligos, probes, primers, viral materials

Research Associate 2 - OEM/Special Projects

Full-TimeUpdated
$27 - $41/hr+ Discretionary bonus
Junior
Bachelor's, Master's
Gaithersburg, MD, USA
In Person
Biology & BiotechBiomedical Engineering & Medical Devices

About the job

Requirements
  • A Master's degree in Biochemistry, Molecular Biology, Biotechnology, Biological Sciences, or a related scientific discipline, with no prior experience required; or a Bachelor's degree in one of those fields or a related scientific discipline with relevant laboratory experience.
  • Experience in molecular biology activities such as DNA/RNA purification, endpoint, real-time, or digital PCR, DNA/RNA electrophoresis, and DNA/RNA processing or modifications.
  • First-hand experience with aseptic techniques.
  • Proficiency with Microsoft Office, particularly Outlook, Word, Excel, and PowerPoint.
  • Demonstrated ability to communicate with internal teams in various formats.
  • Ability to work collaboratively in a team and cross-functional environment, adapt to changes, exert influence positively, self-start, and recognize when stakeholder engagement is appropriate.
  • Ability to take on multiple tasks and responsibilities, adapt to a dynamic work environment, and manage and prioritize multiple tasks and projects to meet established timelines.
  • Ability to perform preliminary data interpretation and analysis and communicate results effectively.
  • Strong organizational, planning, documentation, problem-solving, and troubleshooting abilities.
  • Commitment to laboratory safety, quality, and regulatory compliance standards.
Responsibilities
  • Perform molecular techniques, including nucleic acid purification, gel electrophoresis, RNA transcription, cell culture, and bacterial culture.
  • Perform nucleic acid analysis, including RNA/DNA integrity analysis, real-time qPCR, and digital PCR, and analyze results.
  • Culture cells using aseptic techniques and perform downstream processing of cultured cells.
  • Manufacture products according to provided standard operating procedures and work instructions.
  • Organize projects and data using Excel, Word, PowerPoint, and the EtQ document control system.
  • Work with a supervisor to plan and execute assigned experiments and tasks according to timelines, ensuring documentation meets GLP/GMP requirements.
  • Record test results and data, obtain appropriate approvals, and file records according to established procedures.
  • Maintain, calibrate, and operate equipment according to established protocols; monitor equipment operation against set parameters and refer abnormal results to laboratory management.
  • Plan raw material requirements, maintain reagent inventory, and order reagents as needed through an ERP system such as SAP.
  • Collaborate with cross-functional teams to complete assigned custom project activities.
  • Maintain a clean, organized, and safe laboratory environment while following applicable safety and quality requirements.
  • Contribute to continuous improvement by identifying opportunities to improve laboratory processes, efficiency, and data quality.
  • Accurately document laboratory activities, test results, observations, and data in laboratory notebooks and electronic systems in compliance with applicable quality standards and regulatory requirements.
  • Identify and communicate routine technical issues, recommend solutions, and assist with implementing corrective actions.
  • Assist in developing, revising, and reviewing standard operating procedures, work instructions, and technical documentation.
  • Manage laboratory inventory, monitor reagent supplies, and support procurement activities through ERP systems such as SAP.
  • Follow the company Personal Protection Equipment policy.
  • Perform other duties as required or assigned by management to meet business needs.
Desired Qualifications
  • Three or more years of relevant laboratory experience.
  • Experience working on third-party customer product development and manufacturing.
  • Experience with mammalian cell culture and viral cultures.
  • Experience guiding or training research associates on established procedures.
  • Experience performing data interpretation and analysis after project execution for team review.
  • Proficiency in ERP systems such as IFS, SAP, or Microsoft Dynamics.
  • Experience handling products under an ISO 13485 quality management system.
  • Experience working in a GMP environment, following SOPs, generating customer-facing documents, and preparing documentation for QA review and approval.
  • Ability to operate in line with the company's values of Passion, Curiosity, Integrity, Brilliance, and Respect.

About the company

LGC Group provides life-sciences tools and services worldwide, including oligo components, probes, primers, recombinant viral materials, and proficiency-testing schemes for food safety. Its products support vaccine development, diagnostics, and therapies through mass spectrometry, immunoassays, and nucleic acid chemistry. It differentiates itself with a broad catalog of high-quality tools plus global proficiency-testing services and a wide customer base across diagnostics, healthcare, and pharma. Its goal is to improve healthcare outcomes and help create safer vaccines and treatments by delivering reliable tools and quality services.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

London, United Kingdom

Founded

1841

Get referred to LGC Group

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • LGC opened the CAD$100 million Vaughan center in 2025, expanding pharma supply capacity.
  • DiaMex's December 2024 acquisition strengthened clinical diagnostics and genomics controls.
  • The 2026 DSIT contract and 2027 Irish horseracing renewal extend revenue visibility.

What critics are saying

  • Astorg and Cinven's 2024 acquisition increases integration pressure and leverage discipline.
  • Revelio data shows headcount fell to 3,535 by March 2026, signaling efficiency pressure.
  • A rival could displace LGC if reference-material leadership weakens after the ChromaDex integration.

What makes LGC Group unique

  • LGC's 2026 ChromaDex acquisition deepens reference materials and North American distribution.
  • The 2025 Vaughan synthesis center gives TRC large-scale chemistry capacity worldwide.
  • DSIT awarded LGC a £39.5 million direct-award contract through March 2029.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options
  • Remote Work Options

Growth & Insights and Company News

6 month growth

-8%

1 year growth

-8%

2 year growth

-8%
Samedan Ltd
Oct 12th, 2026
Trio become latest Symbiosis commercial additions.

Trio become latest Symbiosis commercial additions. Symbiosis Pharmaceutical Services has further strengthened its commercial team with three new appointments. Payal Roychoudhury and Joaquín Pérez Fornieles join the Business Development team supporting growth respectively in APAC and Southern Europe and Annie Shafran joins as Inside Sales Manager. A contract development and manufacturing organisation (CDMO), Symbiosis specialises in the aseptic manufacture and fill-finish of injectable medicines for clinical trials and commercial supply. The Stirling-based business is targetting international growth across the Southern Europe, Asia-Pacific and the Middle East territories. Joanne Anderson, Chief Commercial Officer at Symbiosis, said: "We're delighted to welcome Payal, Joaquín and Annie to the Symbiosis team. Payal and Joaquín will help us build relationships in priority international markets, while Annie's new role will strengthen the support we provide from the first client enquiry. Together, they will help more drug developers access the manufacturing capacity and expertise we have invested strongly in." Based in Glasgow, Roychoudhurywill focus on the Asia-Pacific and the Middle East territories. Fornieles, based in Málaga, Spain, has responsibility for Southern Europe and support for other European and selected markets. Shafran, based in Manchester, joins from LGC where she was a Key Account Manager working with international clients. The appointments follow the recent arrival of Jay Chima as Vice President, Business Development, and Jos Vergeest as Senior Business Development Director. Symbiosis' £26 million expansion programme, has increased its aseptic manufacturing capacity for clinical and commercial supply.

LNEG - Laboratório Nacional de Energia e Geologia
Jul 17th, 2026
LNEG and LGC are organising an international workshop on ocean-inspired strategies at SEA TECH WEEK 2026.

LNEG and LGC are organising an international workshop on ocean-inspired strategies at SEA TECH WEEK 2026. Published on 17 July, 2026 Updated on 17 July, 2026 The National Laboratory for Energy and Geology (LNEG, Lisbon) and the Laboratoire de Génie Chimique (LGC, Toulouse) are organising, as part of SEA TECH WEEK 2026, the workshop 'Marine-Inspired Strategies for Enhancing Materials Durability' (STW40), to be held on the morning of 8 October in Brest, France. SEA TECH WEEK is one of the leading international events dedicated to maritime science and technology, bringing together experts, researchers and companies from across Europe in Brest between 6 and 8 October to discuss innovation in the service of the ocean. This year, Portugal is the guest country for the event, which guarantees free registration for Portuguese participants. The STW40 workshop, one of the workshops proposed and selected for inclusion in the event's official programme, forms part of the ALGAPROTEC project (LGC & LNEG), a bilateral cooperation initiative between France and Portugal, funded by the CNRS IRP programme (International Research Project).

LGC Group
May 1st, 2026
LGC acquires SAFEFOOD 360°, expanding its supply chain assurance offering

The acquisition expands our supply chain assurance offerings, while also supporting compliance with major food safety and supplier management requirements globally.

LGC Group
Feb 26th, 2026
LGC Group strengthens its reference material portfolio and North American reach with the acquisition of the ChromaDex Reference Standards business

LGC Group strengthens its reference material portfolio and North American reach with the acquisition of the ChromaDex Reference Standards business. The acquisition further enhances LGC's ability to support pharmaceutical, food, and testing laboratories with trusted reference materials that underpin safety, quality, and regulatory confidence. London, UK, 26 February 2026. LGC Group, a global leader in life sciences, diagnostics, and analytical solutions, today announced the acquisition of the ChromaDex Reference Standards portfolio from Niagen Bioscience (NASDAQ: NAGE). The acquisition expands LGC's reference materials offering and strengthens its commercial reach across North America. The acquisition brings an established portfolio of phytochemical reference materials for the dietary supplements industry into LGC, enabling direct engagement with a broad base of laboratory customers and strengthening LGC's ability to support pharmaceutical companies, testing laboratories, and food producers operating in regulated markets. Bruno Rossi, EVP & General Manager, LGC Standards, said: "The ChromaDex standards portfolio further enhances LGC's ability to support our pharmaceutical customers, testing laboratories, and food producers. Building on LGC's position as a world leader in reference materials and analytical standards, this acquisition expands our North American commercial reach and further supports customers in generating reliable data that safeguards product integrity and confidence across global supply chains." For over 25 years, the ChromaDex Reference Standards portfolio has been built on deep expertise in phytochemical characterisation and analytical verification. The portfolio includes over 3,000 phytochemical reference materials, spanning major classes such as alkaloids, flavonoids, terpenes, carotenoids, organic acids, stilbenoids, vitamins, and select botanicals and plant-based compounds. These materials are widely used to support ingredient verification, method development, authenticity testing, contamination detection, and routine quality control across complex global supply chains. Rob Fried, CEO of Niagen Bioscience, remarked, "This transaction reflects our disciplined focus on what we do best - advancing NAD+ science and delivering clinically proven, patented Niagen(R) solutions across consumer and clinical channels. Selling Reference Standards to LGC is a meaningful step in simplifying our business and ensuring we are allocating capital and talent toward the highest-impact opportunities for shareholders." The acquisition of the ChromaDex Reference Standards portfolio demonstrates LGC's commitment to providing trusted reference materials and measurement solutions that reinforce product safety, quality, and regulatory confidence, advancing its mission of Science for a Safer World. LGC is a global leader in life sciences, diagnostics, and analytical solutions. LGC Group work with partners around the world to address some of society's most important challenges, from diagnosing disease and enabling new treatments to supporting food security and protecting public health. Its science supports discovery, enables better health outcomes and helps safeguard the integrity of food, water, medicines and the environment. Every day, LGC Group provide the components, standards and services that laboratories, manufacturers and regulators rely on to make confident, evidence-based decisions. With operations in 14 countries and more than 180 years of scientific expertise, its work supports public health and sustainability at a global scale. From improving the accuracy of medical testing and verifying the safety of food products, to helping scientists develop the next generation of medicines, its solutions are trusted by customers in more than 170 countries. For further information please contact: Customer contact: Richard Pembrey Sales Director, LGC Standards +1 603 851 2834 Media contact: Magda Bartoszewicz Director Corporate Brand and Communications, LGC Group +44 7408 850 514

CHEManager
Sep 12th, 2025
LGC Opens $100 Million Pharma Synthesis Center in Canada

LGC Group has inaugurated a CAD$100 million (€61.5 million) Organic Chemistry Synthesis Centre of Excellence in Vaughan, canada, significantly expanding global capacity for advanced research chemicals to support the pharmaceutical and life sciences sectors.